Written by students who passed Immediately available after payment Read online or as PDF Wrong document? Swap it for free 4.6 TrustPilot
logo-home
Document preview thumbnail
Preview 4 out of 35 pages
Exam (elaborations)

NSG 5240 ADVANCED PHARMACOLOGY MIDTERM PRACTICE EXAM QUESTIONS AND ANSWERS | VERIFIED AND WELL DETAILED ANSWERS | PLUS RATIONALES | GUARANTEED PASS | LATEST EXAM UPDATE

Document preview thumbnail
Preview 4 out of 35 pages

NSG 5240 ADVANCED PHARMACOLOGY MIDTERM PRACTICE EXAM QUESTIONS AND ANSWERS | VERIFIED AND WELL DETAILED ANSWERS | PLUS RATIONALES | GUARANTEED PASS | LATEST EXAM UPDATE

Content preview

NSG 5240 ADVANCED PHARMACOLOGY MIDTERM PRACTICE EXAM QUESTIONS AND
ANSWERS | VERIFIED AND WELL DETAILED ANSWERS | PLUS RATIONALES | GUARANTEED PASS |
LATEST EXAM UPDATE




Core Domains:

Pharmacokinetics and Pharmacodynamics
Autonomic Nervous System Pharmacology
Cardiovascular and Renal Pharmacology
Central Nervous System Pharmacology
Endocrine and Metabolic Pharmacology
Antimicrobial and Anti-inflammatory Therapy
Oncology and Immunomodulating Agents
Legal, Ethical, and Prescriptive Practice
Special Populations (Pediatric, Geriatric, Pregnancy)
Adverse Drug Reactions and Drug Interactions

Introduction

This comprehensive examination is designed to rigorously assess the advanced practice nursing
student's mastery of pharmacotherapeutic principles essential for safe and effective prescribing. The
exam evaluates foundational knowledge of drug action, clinical application in complex patient
scenarios, and critical decision-making skills required in modern healthcare. Each question is
structured to mirror real-world clinical challenges, integrating pathophysiology with pharmacologic
management. The assessment includes both direct knowledge-based questions and complex clinical
case scenarios, emphasizing the application of pharmacological principles to diverse patient
populations. Successful completion demonstrates readiness for advanced clinical responsibilities and a
deep understanding of the nuanced role of pharmacotherapeutics in patient outcomes.




SECTION ONE: QUESTIONS 1–100
1. A patient with hypertension is prescribed a thiazide diuretic. The nurse practitioner
understands that this medication's primary mechanism of action involves which of the following?

A. Inhibition of the Na+/K+/2Cl- cotransporter in the ascending limb of the loop of Henle
B. Inhibition of the sodium-chloride symporter in the distal convoluted tubule
C. Antagonism of aldosterone receptors in the collecting duct
D. Opening of potassium channels in vascular smooth muscle

🟢B
🔴 Explanation: Thiazide diuretics, such as hydrochlorothiazide, act primarily by inhibiting the
sodium-chloride (Na+/Cl-) symporter located on the luminal membrane of the early distal

,convoluted tubule. This action reduces sodium reabsorption, leading to increased urine output.
Option A describes the action of loop diuretics, Option C describes potassium-sparing diuretics like
spironolactone, and Option D describes the action of minoxidil.




2. A patient on chronic opioid therapy for cancer pain develops constipation. Which medication
is most appropriate for managing this opioid-induced side effect while minimizing systemic
absorption?

A. Docusate sodium
B. Methylnaltrexone
C. Senna
D. Polyethylene glycol

🟢B
🔴 Explanation: Methylnaltrexone is a peripherally acting mu-opioid receptor antagonist (PAMORA)
that is specifically indicated for opioid-induced constipation. Because it is a quaternary amine, it
does not cross the blood-brain barrier, thereby reversing the peripheral effects of opioids on the
gut without affecting central analgesia. Docusate and senna are general stool softeners/stimulants,
and polyethylene glycol is an osmotic laxative, but methylnaltrexone is the targeted agent for this
specific cause.




3. A 75-year-old patient with a history of heart failure and reduced ejection fraction is being
started on carvedilol. What is the most critical monitoring parameter for this patient during the
initiation phase?

A. Serum creatinine
B. Blood glucose levels
C. Body weight and signs of fluid retention
D. Serum potassium

🟢C
🔴 Explanation: Carvedilol, a beta-blocker, can worsen heart failure symptoms upon initiation due
to its negative inotropic effects. Monitoring weight and signs of fluid retention is critical as this
indicates exacerbation of heart failure, necessitating dose adjustment or temporary cessation. While
renal function, glucose, and potassium are important, they are not the most critical during the initial
titration phase for a heart failure patient.




4. Which of the following drugs is known to cause a severe "red man syndrome" due to rapid
histamine release?

A. Gentamicin
B. Vancomycin

,C. Doxycycline
C. Clindamycin

🟢B
🔴 Explanation: Vancomycin is associated with "red man syndrome," characterized by flushing, rash,
and hypotension, which is caused by the rapid infusion of the drug leading to histamine release. To
avoid this, vancomycin should be infused over at least 60 minutes. The other antibiotics listed are
not classically associated with this specific infusion-related reaction.




5. A patient is prescribed digoxin for atrial fibrillation. The nurse practitioner should monitor for
signs of toxicity, particularly in the presence of which concurrent medication?

A. Amiodarone
B. Metoprolol
C. Losartan
D. Atorvastatin

🟢A
🔴 Explanation: Amiodarone increases serum digoxin concentrations by reducing its renal
clearance and displacing it from tissue binding sites. This interaction can lead to digoxin toxicity,
requiring a 50% reduction in the digoxin dose when amiodarone is initiated. Metoprolol, losartan,
and atorvastatin have less significant and clinically relevant interactions with digoxin concerning
toxicity.




6. A patient with a diagnosis of Parkinson's disease is treated with carbidopa-levodopa. A key
principle of administering carbidopa is that it:

A. Crosses the blood-brain barrier to stimulate dopamine receptors
B. Inhibits peripheral metabolism of levodopa, allowing more to reach the brain
C. Acts as a direct dopamine agonist
D. Prevents the breakdown of dopamine in the synapse

🟢B
🔴 Explanation: Carbidopa is a peripheral decarboxylase inhibitor that prevents the conversion of
levodopa to dopamine outside the central nervous system. This action reduces peripheral side
effects (like nausea) and increases the amount of levodopa available to cross the blood-brain
barrier. It does not cross the blood-brain barrier itself to act centrally, nor does it have direct
agonist properties.




7. A pregnant patient at 28 weeks gestation requires antibiotic therapy for a urinary tract
infection. Which of the following is considered the safest and most appropriate choice?

, A. Doxycycline
B. Ciprofloxacin
C. Amoxicillin
D. Sulfamethoxazole-trimethoprim

🟢C
🔴 Explanation: Amoxicillin, a penicillin, is considered safe during all trimesters of pregnancy.
Doxycycline is contraindicated in the second and third trimesters due to effects on fetal bone and
tooth development. Ciprofloxacin is generally avoided due to concerns about arthropathy.
Sulfamethoxazole-trimethoprim is avoided near term due to the risk of kernicterus.




8. A nurse practitioner is reviewing the medication list of a patient with a new diagnosis of
depression. The patient is also taking warfarin for a history of DVT. Which SSRI would be most
prudent to prescribe to minimize the risk of drug-drug interaction?

A. Fluoxetine
B. Paroxetine
C. Sertraline
D. Fluvoxamine

🟢C
🔴 Explanation: Sertraline has a relatively lower potential for drug interactions via CYP450 enzyme
inhibition compared to fluoxetine, paroxetine, and fluvoxamine. Fluoxetine, paroxetine, and
fluvoxamine are potent inhibitors of CYP2D6 or CYP1A2, which can significantly increase warfarin
levels and the risk of bleeding. While sertraline also has some interaction, it is generally considered
the safer choice among the SSRIs in this scenario.




9. The mechanism of action of metformin includes all of the following EXCEPT:

A. Decreased hepatic glucose production
B. Increased insulin secretion from pancreatic beta cells
C. Increased peripheral glucose uptake in skeletal muscle
D. Reduction of intestinal glucose absorption

🟢B
🔴 Explanation: Metformin's primary mechanisms include decreasing hepatic glucose production
(gluconeogenesis), increasing peripheral glucose uptake and utilization, and reducing intestinal
glucose absorption. It does NOT directly stimulate insulin secretion from the pancreas. This is the
mechanism of sulfonylureas and meglitinides, which are insulin secretagogues.




10. A patient on long-term corticosteroid therapy is being evaluated for a minor surgical
procedure. The NP understands that the patient is at risk for which of the following?

Document information

Uploaded on
August 24, 2026
Number of pages
35
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$22.49

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Sold
2
Followers
0
Items
511
Last sold
1 week ago




Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions